Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
about
Eosinophils Reduce Chronic Inflammation in Adipose Tissue by Secreting Th2 Cytokines and Promoting M2 Macrophages PolarizationLessons from mouse models of high-fat diet-induced NAFLDGlial cell line-derived neurotrophic factor protects against high-fat diet-induced hepatic steatosis by suppressing hepatic PPAR-γ expressionPortal Hypertension Complications Are Frequently the First Presentation of NAFLD in Patients Undergoing Liver Transplantation Evaluation.Transient elastography as a screening tool for liver fibrosis in a large hemodialysis populationSupplementation with the extract of schisandrae fructus pulp, seed, or their combination influences the metabolism of lipids and glucose in mice fed with normal and hypercholesterolemic dietDoes bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor?Mediterranean diet and non-alcoholic fatty liver disease: new therapeutic option around the corner?Comments on 'low serum sex hormone binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients'Surgical treatment of nonalcoholic fatty liver disease in severely obese patientsThe heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetesInflammatory cytokine gene expression in mesenteric adipose tissue during acute experimental colitisKetogenesis prevents diet-induced fatty liver injury and hyperglycemiaL-carnitine prevents progression of non-alcoholic steatohepatitis in a mouse model with upregulation of mitochondrial pathway.Circulating level of CTRP1 in patients with nonalcoholic fatty liver disease (NAFLD): is it through insulin resistance?Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis.CHOP links endoplasmic reticulum stress to NF-κB activation in the pathogenesis of nonalcoholic steatohepatitisGreen Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High-Fat DietGut microbiota-derived lipopolysaccharide uptake and trafficking to adipose tissue: implications for inflammation and obesity.Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice.Glycogenic Hepatopathy: Thinking Outside the BoxHigh-Fat, High-Calorie Diet Enhances Mammary Carcinogenesis and Local Inflammation in MMTV-PyMT Mouse Model of Breast CancerBai-Hu-Jia-Ren-Shen-Tang Decoction Reduces Fatty Liver by Activating AMP-Activated Protein Kinase In Vitro and In Vivo.Chronic Liver Disease-Associated Hospitalizations Among Adults with Diabetes, National Inpatient Sample, 2001-2012.Drug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis.Assessment of biochemical parameters and characterization of TNFα -308G/A and PTPN22 +1858C/T gene polymorphisms in the risk of obesity in adolescents.De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucoseChronic treatment with a carbon monoxide releasing molecule reverses dietary induced obesity in mice.Sirtuin 3 (SIRT3) Regulates α-Smooth Muscle Actin (α-SMA) Production through the Succinate Dehydrogenase-G Protein-coupled Receptor 91 (GPR91) Pathway in Hepatic Stellate Cells.Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency.Association between metabolic syndrome and liver histology among NAFLD patients without diabetes.Liver Mitochondrial DNA Copy Number and Deletion Levels May Contribute to Nonalcoholic Fatty Liver Disease Susceptibility.Combined Association of Vitamin D and Sex Hormone Binding Globulin With Nonalcoholic Fatty Liver Disease in Men and Postmenopausal Women: A Cross-Sectional Study.Early effects of a hypocaloric, Mediterranean diet on laboratory parameters in obese individualsModeling human nonalcoholic steatohepatitis-associated changes in drug transporter expression using experimental rodent models.Sex-Dependent Effects of HO-1 Deletion from Adipocytes in Mice.Adipose tissue inflammation in glucose metabolism.Coffee and non-alcoholic fatty liver disease: brewing evidence for hepatoprotection?Morphological and inflammatory changes in visceral adipose tissue during obesity.Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease.
P2860
Q26774613-BAED541B-BE0A-412C-A56A-E0E871355F84Q26829532-FA498F1F-FD73-4FCD-827B-DF3F7A3A190DQ28354027-7EAD1C2C-DD8B-4070-9339-66B645E8D63EQ33430862-78817977-AB88-41FA-8E91-DC859387281CQ33577504-7A1A4ACF-186E-46C3-B193-9ACF84A470AEQ33614303-E3886709-146B-462A-9CD0-EEF4D4BEA84AQ33693385-EA157628-1448-42B1-98AA-E9EF31D9961BQ33780152-F3E5C863-BFBE-488A-8F28-A5AA8A956C4AQ34241481-A51C5D54-F6A6-475D-86AB-CF3A502754B8Q34446294-7D65BAF9-EF04-4759-A05C-AB39A9539382Q35048289-A820BE0B-F4CC-454A-99FE-9704E4598CBDQ35080569-D5E91149-EAAF-4693-851B-86F924E1A49BQ35145496-3C2D86C9-E330-4BFE-8F8E-8A89299D52ADQ35199067-265E1273-51F0-4CA2-AE24-D599FCE50FDBQ35576521-85A9883D-1860-4E9B-8613-48772265A1F0Q35716357-102D37EB-A9DA-487A-9BD6-00C19EDCEE97Q35717788-645135D3-5FD6-4DE4-B442-8123055A6299Q35832166-E7FFF3C7-2458-4A7C-BF6F-1AB650484A35Q35880172-5A12207B-7F79-462D-BDB9-B163EF5F26DDQ35893594-1118A13D-4165-4254-B227-6C5C1F8B2055Q35903167-A69D7557-4889-41F8-956D-61E9515B02D4Q36102802-D75BE9E0-3B6D-45CA-A04E-5E4CB9000756Q36174315-81A6E700-1693-4CEB-A0DD-F3F6EB974E78Q36180921-71614390-4AC4-46B9-B51E-5370BF177D28Q36391044-DF842EB5-55E5-4D3B-9BCC-AB233433A2F6Q36502041-378D5A3E-C98E-4743-A704-B88D26996F13Q36800168-D7C42387-6CCF-424A-A503-E7DADEE6A6B1Q36812394-242F46CF-6E41-4681-AC2F-72B7D4316242Q36876226-20688609-99CF-4E7B-B53F-EF9AC8F14EB3Q37245901-84B0C5AA-F92B-4C65-988B-9A4D77E0E05DQ37454017-C61F54B3-91C5-4CB7-B967-DA24451C7006Q37587055-7F914AB2-ABDB-46A0-BE2A-BF7ED0641E91Q37624134-CA9DAC17-8054-4269-9A18-FBECC9371BE6Q37651059-89F83A25-35B5-4230-A002-466161D3F613Q37663390-AB9225B6-D33C-45C1-B663-B545007972A7Q37729259-D9DC3139-E8D8-407F-929D-8BAF8F1BDAC4Q38139293-BBA02AA0-E36F-45E8-B8EA-B83C82A4A1CDQ38160516-CFF9DD6B-5812-4A43-B7F1-A01ED5CC76B9Q38172822-A353E1CD-24D2-4D71-AA88-D81F8DB1F56BQ38246145-1DA94945-CEDD-4F88-B3C3-CADE000A24CD
P2860
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
@ast
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
@en
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
@en-gb
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
@nl
type
label
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
@ast
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
@en
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
@en-gb
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
@nl
prefLabel
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
@ast
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
@en
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
@en-gb
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
@nl
P2860
P921
P3181
P356
P1476
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
@en
P2093
Howard C Masuoka
Naga Chalasani
P2860
P304
P3181
P356
10.1111/NYAS.12016
P407
P5008
P577
2013-04-01T00:00:00Z